SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,259,112 | +325.5% | 5,796 | -96.0% | 8.45% | +221.4% |
| Q2 2023 | $16,513,784 | -75.3% | 144,200 | -70.3% | 2.63% | -82.7% |
| Q1 2023 | $66,850,858 | +1721.4% | 485,024 | +1612.4% | 15.17% | +1613.8% |
| Q4 2022 | $3,670,224 | -67.5% | 28,324 | -72.2% | 0.88% | -60.6% |
| Q3 2022 | $11,276,000 | +20.4% | 102,009 | -18.4% | 2.25% | +31.5% |
| Q2 2022 | $9,369,000 | -73.9% | 125,000 | -68.7% | 1.71% | -68.1% |
| Q4 2021 | $35,962,000 | +5.6% | 399,400 | +8.5% | 5.36% | +123.5% |
| Q3 2021 | $34,051,000 | +776.0% | 368,196 | +636.4% | 2.40% | +663.4% |
| Q2 2021 | $3,887,000 | -90.6% | 50,000 | -91.0% | 0.31% | -77.5% |
| Q1 2021 | $41,441,000 | -82.3% | 556,034 | -59.5% | 1.40% | -86.5% |
| Q4 2020 | $233,897,000 | +163.3% | 1,371,900 | +116.8% | 10.31% | +60.4% |
| Q3 2020 | $88,848,000 | +21206.5% | 632,700 | +24234.6% | 6.43% | +19384.8% |
| Q2 2020 | $417,000 | -95.8% | 2,600 | -97.5% | 0.03% | -95.6% |
| Q1 2020 | $10,036,000 | -24.2% | 102,600 | 0.0% | 0.76% | -64.8% |
| Q4 2019 | $13,240,000 | – | 102,600 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |